Barnik Invest Group Announces Joint Venture Partnership with Dynalis Pharma

Stockholm, Sweden – Barnik Invest Group, today announced a joint venture partnership with Dynalis Pharma, a renowned Swiss pharmaceutical company, to establish BoniPharmex. This strategic collaboration aims to leverage the combined expertise of both companies to develop and commercialize innovative probiotic and food supplement products. The company will leverage the expertise of both Dynalis Pharma […]